AtheroGenics, Inc. · Alpharetta, GA United States
| 8995 Westside Pkwy. | Phone: 678-336-2500 |
| Alpharetta, GA | Fax: 678-336-2501 |
| 30004 | |
| United States | 
Map This Company |
AtheroGenics, Inc. Rankings
Company Description
Drug company AtheroGenics developed drug candidates for the treatment of chronic inflammatory diseases, including diabetes and coronary heart disease. Its lead candidate, AGI-1067, was an oral drug intended to improve blood sugar levels. Development of the therapeutic compound was ongoing despite disappointing results from a major AGI-1067 clinical trial, which led to the termination of a licensing agreement with
AtheroGenics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
Executives
2 executives listed for AtheroGenics, Inc.'s Alpharetta, GA location.
| Chairman | Michael Henos | |
|---|---|---|
| President, CFO, and Secretary | Charles Deignan |